We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$853M
AUM Growth
+$41.2M
Cap. Flow
-$4.27M
Cap. Flow %
-0.5%
Top 10 Hldgs %
45.97%
Holding
2,993
New
166
Increased
1,040
Reduced
961
Closed
220

Sector Composition

Rank Sector Weight
1 Financials 17.04%
2 Technology 13.3%
3 Healthcare 7.37%
4 Industrials 3.43%
5 Consumer Staples 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SH icon
2076
ProShares Short S&P500
SH
$843M
$3K ﹤0.01%
50
BMRC icon
2077
Bank of Marin Bancorp
BMRC
$459M
$3K ﹤0.01%
137
-49
-26% -$1.42K
SGMO
2078
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.99K ﹤0.01%
1,700
-1,958
-54% -$5.59K
FOLD
2079
DELISTED
Amicus Therapeutics
FOLD
$2.98K ﹤0.01%
269
-75
-22% -$924
FRT icon
2080
Federal Realty Investment Trust
FRT
$10.3B
$2.96K ﹤0.01%
30
SIGI icon
2081
Selective Insurance
SIGI
$5.73B
$2.96K ﹤0.01%
31
+3
+11% +$287
CSL icon
2082
Carlisle Companies
CSL
$15.4B
$2.94K ﹤0.01%
13
+6
+86% +$1.46K
RDN icon
2083
Radian Group
RDN
$4.93B
$2.94K ﹤0.01%
133
+47
+55% +$1K
WSFS icon
2084
WSFS Financial
WSFS
$4.15B
$2.93K ﹤0.01%
78
AX icon
2085
Axos Financial
AX
$5.68B
$2.92K ﹤0.01%
79
BFST icon
2086
Business First Bancshares
BFST
$1.03B
$2.91K ﹤0.01%
170
+162
+2,025% +$3.22K
P
2087
Everpure Inc
P
$29.9B
$2.91K ﹤0.01%
114
-40
-26% -$1.08K
OTTR icon
2088
Otter Tail
OTTR
$3.94B
$2.89K ﹤0.01%
40
-3
-7% -$199
VKTX icon
2089
Viking Therapeutics
VKTX
$4B
$2.88K ﹤0.01%
+173
New +$1.79K
TR icon
2090
Tootsie Roll Industries
TR
$2.98B
$2.87K ﹤0.01%
70
+10
+17% +$399
AGX icon
2091
Argan
AGX
$8.37B
$2.87K ﹤0.01%
71
+65
+1,083% +$2.55K
AUPH icon
2092
Aurinia Pharmaceuticals
AUPH
$2.11B
$2.87K ﹤0.01%
262
-5
-2% -$44
AMAL icon
2093
Amalgamated Financial
AMAL
$1.49B
$2.87K ﹤0.01%
162
+78
+93% +$1.72K
MTW icon
2094
Manitowoc
MTW
$675M
$2.85K ﹤0.01%
167
+11
+7% +$165
NIC icon
2095
Nicolet Bankshares
NIC
$3.62B
$2.84K ﹤0.01%
45
+33
+275% +$2.38K
BSAC icon
2096
Banco Santander Chile
BSAC
$16.6B
$2.83K ﹤0.01%
159
AGEN
2097
Agenus
AGEN
$290M
$2.83K ﹤0.01%
95
-68,493
-100% -$2.89M
ROCC
2098
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$2.82K ﹤0.01%
69
-46
-40% -$1.88K
ALV icon
2099
Autoliv
ALV
$9B
$2.8K ﹤0.01%
30
ARKX icon
2100
ARK Space & Defense Innovation ETF
ARKX
$850M
$2.8K ﹤0.01%
200

Similar funds

Lindbrook Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Lindbrook Capital held 2,993 positions worth $853M, up 5.1% from $812M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital's Q1 2023 filing shows 166 new, 1,040 increased, 961 reduced and 220 closed positions. Its largest new stake was Hess Midstream: 4,984 shares worth $144K. The largest sale was Oramed Pharmaceuticals, an estimated $4.61M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • Lindbrook Capital's largest Q1 2023 buy was Hess Midstream: 4,984 shares worth $144K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q1 2023, an estimated $12.7M increase.
  • Lindbrook Capital's biggest Q1 2023 reduction was Agenus, cutting an estimated $2.89M.
  • Lindbrook Capital fully exited Oramed Pharmaceuticals in Q1 2023, selling an estimated $4.61M.
  • Lindbrook Capital's ten largest holdings make up 46% of its $853M portfolio in Q1 2023.
  • Lindbrook Capital opened 166 new positions and closed 220 in Q1 2023.
  • Lindbrook Capital's portfolio value rose 5.1% quarter-over-quarter to $853M.

Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.